High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma

[1]  M. Kanehisa,et al.  KEGG for taxonomy-based analysis of pathways and genomes , 2022, Nucleic Acids Res..

[2]  C. Wanqing,et al.  Current cancer burden in China: epidemiology, etiology, and prevention , 2022, Cancer biology & medicine.

[3]  Ning Zhang,et al.  The advanced development of molecular targeted therapy for hepatocellular carcinoma , 2022, Cancer biology & medicine.

[4]  D. Peeper,et al.  RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells , 2022, Cell reports. Medicine.

[5]  Sharan Janjuha,et al.  Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing , 2021, Nature Communications.

[6]  B. Sangro,et al.  Advances in immunotherapy for hepatocellular carcinoma , 2021, Nature Reviews Gastroenterology & Hepatology.

[7]  Haibo Zhou,et al.  Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes , 2021, Journal of translational medicine.

[8]  I. Tai,et al.  Adaptive response of resistant cancer cells to chemotherapy , 2020, Cancer biology & medicine.

[9]  M. Pasca di Magliano,et al.  Targeting the Microenvironment to Overcome Gemcitabine Resistance in Pancreatic Cancer , 2020, Cancer Research.

[10]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[11]  Yuanyuan Chu,et al.  LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13 , 2020, Autophagy.

[12]  J. Debnath,et al.  Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I , 2020, Nature.

[13]  K. Murphy,et al.  Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. , 2020, Cancer cell.

[14]  Michelle A. Anderson,et al.  Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. , 2020, Cancer discovery.

[15]  S. Kaneko,et al.  Immune cell therapy for hepatocellular carcinoma , 2019, Journal of Hematology & Oncology.

[16]  Yongshuai Jiang,et al.  PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations , 2019, Human vaccines & immunotherapeutics.

[17]  H. Walczak,et al.  Linear ubiquitination at a glance , 2019, Journal of Cell Science.

[18]  Xianqun Fan,et al.  Ring finger protein 31–mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function , 2018, The Journal of Biological Chemistry.

[19]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[20]  E. Scarpi,et al.  Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinoma. , 2018, Critical reviews in oncology/hematology.

[21]  N. Chaput,et al.  Enterocolitis due to immune checkpoint inhibitors: a systematic review , 2018, Gut.

[22]  J. Llovet,et al.  Molecular therapies and precision medicine for hepatocellular carcinoma , 2018, Nature Reviews Clinical Oncology.

[23]  Gang Yang,et al.  Tumor microenvironment participates in metastasis of pancreatic cancer , 2018, Molecular Cancer.

[24]  Xueqiang Zhao,et al.  RNF31 Regulates Skin Homeostasis by Protecting Epidermal Keratinocytes from Cell Death , 2018, The Journal of Immunology.

[25]  T. Whiteside.  FOXP3+ Treg as a therapeutic target for promoting anti-tumor immunity , 2018, Expert opinion on therapeutic targets.

[26]  J. Marquardt,et al.  Immunotherapy of Hepatocellular Carcinoma , 2018, Oncology Research and Treatment.

[27]  E. Jaffee,et al.  Tumor Mutational Burden and Response Rate to PD-1 Inhibition. , 2017, The New England journal of medicine.

[28]  B. Sangro,et al.  Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes , 2017, Clinical Cancer Research.

[29]  K. Ashkan,et al.  Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme , 2017, Human vaccines & immunotherapeutics.

[30]  Q. Lai,et al.  Hepatocellular cancer and recurrence after liver transplantation: what about the impact of immunosuppression? , 2017, Translational gastroenterology and hepatology.

[31]  Freeman,et al.  PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity , 2017, The Journal of experimental medicine.

[32]  J. Moorman,et al.  The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7 , 2016, Journal of Virology.

[33]  F. Marra,et al.  Challenges of advanced hepatocellular carcinoma , 2016, World journal of gastroenterology.

[34]  Jian Zhu,et al.  Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression , 2016, BMC Cancer.

[35]  Jian Zhu,et al.  Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression , 2016, BMC Cancer.

[36]  Xiuheng Liu,et al.  miR-503 suppresses tumor cell proliferation and metastasis by directly targeting RNF31 in prostate cancer. , 2015, Biochemical and biophysical research communications.

[37]  K. Dahlman-Wright,et al.  RING finger protein 31 promotes p53 degradation in breast cancer cells , 2015, Oncogene.

[38]  R. Hay,et al.  E3 ubiquitin ligase HOIP attenuates apoptotic cell death induced by cisplatin. , 2014, Cancer research.

[39]  K. Dahlman-Wright,et al.  The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation , 2014, Oncogene.

[40]  J. Zimmer,et al.  Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia , 2013, Proceedings of the National Academy of Sciences.

[41]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[42]  K. Margolin,et al.  Cytokines in Cancer Immunotherapy , 2011, Cancers.

[43]  R. Kurzrock,et al.  Autophagy as a target for anticancer therapy , 2011, Nature Reviews Clinical Oncology.

[44]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[45]  R. Tesi.  MDSC; the Most Important Cell You Have Never Heard Of. , 2019, Trends in pharmacological sciences.

[46]  D. Vučić,et al.  Intracellular regulation of TNF activity in health and disease. , 2018, Cytokine.

[47]  G. Gores,et al.  Hepatocellular carcinoma , 2016, Nature Reviews Disease Primers.